CoreWeave Just Locked In Meta and Anthropic in 48 Hours. Is CRWV a Buy in 2026?

The Week That Rewrote CoreWeave''s Backlog

CoreWeave had the kind of 48 hours that changes how Wall Street models a company. On Thursday, the AI cloud provider announced a $21 billion expansion of its existing contract with Meta Platforms, extending compute capacity through December 2032. Less than 24 hours later, it dropped a multi-year agreement with Anthropic to power Claude model training and deployment. CRWV jumped roughly 13% on Friday, closing in on $102 after spending most of the past six months in the penalty box, down around 33% from prior highs.

This is the kind of stretch that forces a real question for retail investors: is CoreWeave stock a buy in 2026, or is the backlog story already priced in?

Why the Meta and Anthropic Deals Actually Matter

The headline numbers are impressive on their own, but the structural shift underneath them is what matters for the investment case.

• Total contracted backlog now sits near $87.8 billion on a pro-forma basis, with Meta alone representing roughly 40% of that figure through 2032.
• Nine of the top 10 AI model providers now run workloads on CoreWeave''s platform, including Anthropic, which had previously leaned almost entirely on Amazon AWS and Alphabet Google Cloud for compute.
• The Meta capacity will include first deployments of Nvidia''s Vera Rubin system, giving CoreWeave a meaningful hardware lead over hyperscaler rivals still waiting in the Nvidia allocation queue.

The Anthropic win is the one that should catch your attention. Anthropic already has billions committed to Microsoft Azure and Google TPU capacity, yet it still chose to route Claude workloads through CoreWeave. That is a strong signal that hyperscaler capacity is genuinely constrained and that specialized GPU clouds are not just a stopgap. They are becoming permanent infrastructure.

The Debt Problem Nobody Wants to Talk About

Here is where the story gets uncomfortable, and where most bullish coverage glosses over the real risk. To fund this buildout, CoreWeave priced two simultaneous offerings this week: $3.5 billion in 1.75% convertible notes due 2032 (upsized from the original $3 billion target) and $1.75 billion in senior notes yielding 9.75% due 2031. That 9.75% coupon tells you exactly how credit markets are pricing CoreWeave''s balance sheet risk. This is not investment grade pricing. This is high-yield territory, and it reflects the reality that CoreWeave is financing a massive data center expansion with expensive debt while still posting negative trailing EPS of roughly -$2.93.

The company carries no meaningful P/E ratio because it is not consistently profitable, which means traditional valuation multiples do not apply cleanly. What investors are really underwriting is a price-to-sales bet against future contracted revenue, and on that basis the numbers actually start to make sense. At a market cap near $46.7 billion against an $87.8 billion multi-year backlog, the forward revenue coverage looks reasonable, assuming execution holds and customer concentration does not become a liability.

CRWV Stock Forecast 2026: Bull, Base, and Bear Cases

Anyone telling you CoreWeave is a sure thing is selling you something. The honest answer requires probability weighting, not cheerleading.

Bull case (roughly 35% probability): Vera Rubin deployments go smoothly, Anthropic expands its phased rollout meaningfully in 2027, and CoreWeave converts backlog into revenue ahead of schedule. In this scenario, the stock pushes toward the Evercore ISI price target of $120 and potentially higher. Per Reuters reporting, institutional demand for dedicated AI compute capacity remains structurally tight through at least 2027.

Base case (roughly 45% probability): CRWV trades in a wide range between $85 and $115 as the market digests execution milestones, debt servicing costs, and the inevitable quarter where capex spikes faster than revenue recognition. This is the scenario the average analyst target of $120.79 implicitly reflects, with a 32-analyst consensus rating of Buy.

Bear case (roughly 20% probability): Customer concentration bites hard, a single Meta renegotiation or Anthropic chip independence push (the company is reportedly exploring custom silicon, according to Bloomberg) compresses the backlog narrative, and the 9.75% coupons start eating into free cash flow faster than expected. Downside from here could reach the mid-$60s before finding support.

Is CoreWeave Stock a Buy Right Now?

If you already own CRWV, this week validated the thesis. If you are looking to start a position, the honest take is that chasing a 13% single-session pop into a stock with this much debt and customer concentration is not where experienced investors find their best entries. The more disciplined move is waiting for the inevitable pullback when the next convertible note offering or quarterly capex print spooks short-term holders.

CoreWeave is positioned as the purest public market bet on specialized AI infrastructure, full stop. That thesis has real legs given what Meta, Anthropic, and the rest of the Magnificent Seven are spending on compute. It also carries real balance sheet risk that retail investors should not hand-wave away just because the backlog headline looks spectacular. The investment case works if you size the position appropriately and treat it as a high-conviction, high-volatility AI infrastructure play rather than a core portfolio holding.

---

Disclaimer: This article is for informational purposes only and should not be considered financial advice. Stock investing involves significant risk, including potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.